Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis

被引:0
|
作者
Eric L Matteson
Tim Bongartz
机构
[1] and T Bongartz is an Assistant Professor of Medicine and a Resident in Internal Medicine,EL Matteson is a Professor of Medicine and a Consultant at the Division of Rheumatology
[2] at the Mayo Clinic in Rochester,undefined
[3] MN,undefined
[4] USA.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:14 / 15
页数:1
相关论文
共 50 条
  • [1] Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis
    Matteson, Eric L.
    Bongartz, Tim
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (01): : 14 - 15
  • [2] Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis
    Ranganathan, A
    [J]. PHARMACOGENOMICS, 2005, 6 (05) : 481 - 490
  • [3] The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study
    Wu, Chun-Ying
    Chen, Der-Yuan
    Shen, Jui-Lung
    Ho, Hsiu J.
    Chen, Chih-Chiang
    Kuo, Ken N.
    Liu, Han-Nan
    Chang, Yun-Ting
    Chen, Yi-Ju
    [J]. ARTHRITIS RESEARCH & THERAPY, 2014, 16 (05)
  • [4] The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study
    Chun-Ying Wu
    Der-Yuan Chen
    Jui-Lung Shen
    Hsiu J Ho
    Chih-Chiang Chen
    Ken N Kuo
    Han-Nan Liu
    Yun-Ting Chang
    Yi-Ju Chen
    [J]. Arthritis Research & Therapy, 16
  • [5] Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Cook, E. Francis
    Carney, Greg
    Schneeweiss, Sebastian
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2757 - 2764
  • [6] Erratum to: The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study
    Chun-Ying Wu
    Der-Yuan Chen
    Jui-Lung Shen
    Hsiu J. Ho
    Chih-Chiang Chen
    Ken N. Kuo
    Han-Nan Liu
    Yun-Ting Chang
    Yi-Ju Chen
    [J]. Arthritis Research & Therapy, 18
  • [7] Efficacy and security of tumor necrosis factor antagonists in the treatment of rheumatoid arthritis
    Perez Pampin, Eva
    Carnota, Juan Jesus Gomez-Reino
    [J]. MEDICINA CLINICA, 2008, 130 (05): : 179 - 187
  • [8] Apoptosis as a Mechanism of Action of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis
    Makrygiannakis, Dimitrios
    Catrina, Anca Irinel
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 679 - 685
  • [9] Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Francis Cook, E.
    Carney, Greg
    Schneeweiss, Sebastian
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S19 - S19
  • [10] Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
    Martinez-Santana, Virginia
    Gonzalez-Sarmiento, E.
    Calleja-Hernandez, M. A.
    Sanchez-Sanchez, T.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 719 - 727